Veru Inc. Stock Performance

Open $2.48	Prev. Close $2.39	Circuit Range N/A
Day Range $2.46 - $2.48	Year Range $2.06 - $7.23	Volume 968
Average Traded $2.47

Veru Inc. Share Price Today

As of 9 October 2026, Veru Inc.'s share price is $2.45. The stock opened at $2.48, compared to its previous close of $2.39. During today's trading session, Veru Inc.'s share price traded between $2.46 and $2.48, with an average price of $2.47. Over the past 52 weeks, the stock has recorded a high of $7.23 and a low of $2.06. In terms of performance, Veru Inc.'s share price has risen by 8.41% over the last six months and is down 17.37% on a year-on-year basis.

Veru Inc. Share Price Chart

$2.46$2.48

Veru Inc. Stock Fundamentals & Key Indicators

Market Cap $35.88M	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-0.80	Revenue (TTM) $0.00	Return On Equity (TTM) -47.96%
Profit Margin N/A	Debt to Equity 0.00	Quarterly Earnings Growth YoY -582.07%

Veru Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	$1.45	-$5.33	-$2.74	-$6.99
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-467.59%	48.59%	-155.11%

Veru Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$39.35	$16.30	$0.00	$0.00
Net Profit	-$83.78	-$93.15	-$37.80	-$22.73
Net Profit Margin	-212.91%	-571.47%	N/A	N/A
Income Change	N/A	-11.18%	59.42%	39.87%

About Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Veru Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$2.61	$2.46	-8.04%
Sep 2026	$2.82	$2.67	-2.73%
Aug 2026	$2.26	$2.75	+23.04%
Jul 2026	$3.15	$2.23	-28.82%
Jun 2026	$2.28	$3.14	+33.33%
May 2026	$2.26	$2.35	+4.20%
Apr 2026	$2.30	$2.26	+1.35%
Mar 2026	$2.50	$2.23	-12.55%
Feb 2026	$2.54	$2.55	+0.79%
Jan 2026	$2.18	$2.53	+18.78%
Dec 2025	$2.48	$2.13	-14.11%
Nov 2025	$2.95	$2.48	-16.36%

VERU Share Price FAQs

What is Veru Inc. share price today?

Veru Inc. share price today is $2.45 as on October 9, 2026 at 10:09 pm IST.

What is the 52 week high and 52 week low of Veru Inc. stock?

The 52 week high of Veru Inc. stock is $7.23, while the 52 week low is $2.06 as of 9 Oct '26.

What is VERU's market capitalisation today?

VERU market capitalisation is $35.88M as of October 9, 2026, at 10:17 pm IST.

What is VERU's net income for the last quarter?

VERU's net income for the last quarter is -6.99B USD.

What is the 5 year returns of VERU?

The 5 year returns of VERU is -70.01% as on 9 Oct '26.

What is the high & low stock price of VERU today?

VERU stock price hit a high of $2.48 and low of $2.46 as of 9 Oct '26.

Can I buy VERU shares in India?

Yes. You can buy VERU in India by opening an international trading account.